CalciMedica Changes Auditors to BDO USA, P.A.

Ticker: CALC · Form: 8-K · Filed: Apr 10, 2024 · CIK: 1534133

Calcimedica, INC. 8-K Filing Summary
FieldDetail
CompanyCalcimedica, INC. (CALC)
Form Type8-K
Filed DateApr 10, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, accounting

TL;DR

CalciMedica swapped PwC for BDO as its auditor, no drama reported.

AI Summary

On April 5, 2024, CalciMedica, Inc. announced a change in its principal accounting firm, dismissing PricewaterhouseCoopers LLP and engaging BDO USA, P.A. as its new independent registered public accounting firm. This change was made with the concurrence of the outgoing auditor, and the company stated there were no disagreements or reportable events that would have caused PricewaterhouseCoopers LLP to resign or be dismissed.

Why It Matters

A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors may monitor closely.

Risk Assessment

Risk Level: low — The filing reports a routine change of auditors without any stated disagreements, indicating low immediate risk.

Key Players & Entities

FAQ

When did CalciMedica, Inc. report this change in its principal accounting firm?

CalciMedica, Inc. reported this change on April 5, 2024.

Who was CalciMedica, Inc.'s principal accounting firm prior to this change?

Prior to this change, CalciMedica, Inc.'s principal accounting firm was PricewaterhouseCoopers LLP.

Who is CalciMedica, Inc.'s new independent registered public accounting firm?

CalciMedica, Inc.'s new independent registered public accounting firm is BDO USA, P.A.

Were there any disagreements between CalciMedica, Inc. and PricewaterhouseCoopers LLP?

No, the filing states there were no disagreements or reportable events that would have caused PricewaterhouseCoopers LLP to resign or be dismissed.

Did the outgoing auditor concur with the company's decision?

Yes, the change was made with the concurrence of the outgoing auditor, PricewaterhouseCoopers LLP.

Filing Stats: 978 words · 4 min read · ~3 pages · Grade level 14 · Accepted 2024-04-10 17:12:30

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CalciMedica, Inc. Date: April 10, 2024 By: /s/ A. Rachel Leheny, Ph. D. Name: Title: A. Rachel Leheny, Ph. D. Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing